<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04260074</url>
  </required_header>
  <id_info>
    <org_study_id>N-20190047</org_study_id>
    <nct_id>NCT04260074</nct_id>
  </id_info>
  <brief_title>Epigenetic Changes in Head and Neck Cancer</brief_title>
  <official_title>Biomarkers in Head and Neck Cancer - Epigenetic Changes and Hypermethylation of Promoter-regions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aalborg University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aalborg University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      With this study, the investigators will investigate the epigenetic changes, which may
      contribute to the development of head and neck squamous cell carcinomas.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">February 10, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in epigenetic changes</measure>
    <time_frame>6 months</time_frame>
    <description>Differences between tumor- and healthy group</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Head and Neck Cancer</condition>
  <condition>Squamous Cell Carcinoma</condition>
  <condition>Head and Neck Squamous Cell Carcinoma</condition>
  <condition>Head and Neck Neoplasms</condition>
  <arm_group>
    <arm_group_label>Oral Cancer group</arm_group_label>
    <description>20 consecutive patients with oral squamous cell carcinoma referred to the Department of Otolaryngology - Head and Neck Surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy oral mucosa group</arm_group_label>
    <description>20 consecutive patients referred to a private clinic for oral and maxillofacial surgery with normal buccal mucosa upon examination.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Biopsies from tumour and healthy buccal mucosa. Blood samples from both case and control
      group.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cancergroup:

        Patients referred to The Department of Otolaryngology - Head and Neck surgery

        Controlgroup:

        Patients referred to a private clinic for oral and maxillofacial surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Cancer group:

        Inclusion Criteria :

          -  Written informed consent

          -  Histologically confirmed oral squamous cell carcinoma

        Exclusion Criteria:

          -  History of cancer

          -  Uncontrolled comorbidity

        Control group:

        Inclusion Criteria :

          -  Written informed consent

          -  Normal buccal mucosal surface.

          -  Normal ENT-examination

        Exclusion Criteria:

          -  History of cancer

          -  Uncontrolled comorbidity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Gaihede, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Otolaryngology - Head and Neck Surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian Danstrup, M.D</last_name>
    <phone>+45 23800598</phone>
    <email>csd@rn.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Otolaryngology - Head and Neck Surgery</name>
      <address>
        <city>Aalborg</city>
        <zip>9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Danstrup, M.D</last_name>
      <phone>+45 23800598</phone>
      <email>csd@rn.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 5, 2020</study_first_submitted>
  <study_first_submitted_qc>February 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 7, 2020</study_first_posted>
  <last_update_submitted>February 6, 2020</last_update_submitted>
  <last_update_submitted_qc>February 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aalborg University Hospital</investigator_affiliation>
    <investigator_full_name>Christian Sander Danstrup</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Head and Neck Neoplasms</mesh_term>
    <mesh_term>Squamous Cell Carcinoma of Head and Neck</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

